Suchergebnisse - "Zhong, Peng"

PubPharm (8)

1

MOTS-c Peptide Attenuated Diabetic Cardiomyopathy in STZ-Induced Type 1 Diabetic Mouse Model

enthalten in: Cardiovascular drugs and therapy | 2023

von Wu, N. | Shen, C. | Wang, J. | +2

2

Sotagliflozin attenuates cardiac dysfunction and remodeling in myocardial infarction rats

enthalten in: Heliyon | 2023

von Zhong, P. | Zhang, J. | Wei, Y. | +2

3

Epicardial adipose tissue (EAT) : A prognostic factor in patients with non-ischemic cardiomyopathy

enthalten in: International journal of cardiology | 2022

von Zhong, P. | Huang, H.

CommentOn: Int J Cardiol. 2022 Jun 1;356:60-65. - PMID 35358639

4

AAV9-Mediated Cardiac CNTF Overexpression Exacerbated Adverse Cardiac Remodeling in Streptozotocin-Induced Type 1 Diabetic Models

enthalten in: Cardiovascular toxicology | 2022

von Zhong, P. | Peng, J. | Liu, T. | +1

ErratumIn: Cardiovasc Toxicol. 2021 Dec 8;:. - PMID 34878621

5

AAV9-Mediated Cardiac CNTF Overexpression Exacerbated Adverse Cardiac Remodeling in Streptozotocin-Induced Type 1 Diabetic Models

enthalten in: Cardiovascular toxicology | 2021

von Zhong, P. | Peng, J. | Liu, T. | +1

6

AAV9-Mediated Cardiac CNTF Overexpression Exacerbated Adverse Cardiac Remodeling in Streptozotocin-Induced Type 1 Diabetic Models

enthalten in: Cardiovascular toxicology | 2021

von Zhong, P. | Peng, J. | Liu, T. | +1

7

AAV9-Mediated Cardiac CNTF Overexpression Exacerbated Adverse Cardiac Remodeling in Streptozotocin-Induced Type 1 Diabetic Models

enthalten in: Cardiovascular toxicology | 2021

von Zhong, P. | Peng, J. | Liu, T. | +1

8

Role of CaMKII in free fatty acid/hyperlipidemia-induced cardiac remodeling both in vitro and in vivo

enthalten in: Journal of molecular and cellular cardiology | 2017

von Zhong, P. | Quan, D. | Peng, J. | +4

ErratumIn: J Mol Cell Cardiol. 2018 May 2;:. - PMID 29729805

1
[1]